ArticleInfection prevention in practice2026
Mpox in advanced AIDS with concurrent opportunistic infections: periprocedural management challenges.
Article in Infection prevention in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mpox can be severe and prolonged in people with advanced human immunodeficiency virus. Concurrent opportunistic infections and diagnostic uncertainty may delay definitive therapy and complicate infection control and procedural planning. Presentation of the case: A 42-year-old man with long-standing acquired immunodeficiency syndrome (AIDS) and inconsistent antiretroviral adherence presented with fever, cough, diffuse lymphadenopathy, and multiple papules on the skin, some being violaceous and crusted and others epithelialized. Imaging showed diffuse lymphadenopathy and pulmonary nodules. Broad differential diagnoses included disseminated coccidiomycosis, Pneumocystis pneumonia, Kaposi sarcoma, human herpesvirus 8-associated disease, and mpox. Cell-free DNA next-generation sequencing demonstrated mpox clade II and concurrent pathogens. Tecovirimat was obtained under the Centers for Disease Control and Prevention (CDC) expanded-access protocol and administered for 14 days with epithelialization of skin lesions, suggesting resolution of mpox except for persistent mpox polymerase chain reaction positivity of one epithelialized lesion.Our team deferred inpatient lymph node biopsy because neither the CDC nor World Health Organization guidelines provide specific periprocedural isolation workflows (e.g. procedure room selection, anaesthesia considerations, staff personal protective equipment beyond standard recommendations, and postprocedure decontamination) for mpox patients, and we found no state, national, or international guidelines addressing periprocedural isolation precautions for mpox. Conclusion: This case highlights the management complexity of mpox in advanced AIDS with multiple concurrent opportunistic infections. It also underscores operational gaps for time-sensitive procedures in patients requiring mpox isolation precautions, emphasizing the need for practical periprocedural guidance and evolving CDC recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.